Interleukin enhancer-binding factor 3 (ILF3) (N-Term) antibody
Quick Overview for Interleukin enhancer-binding factor 3 (ILF3) (N-Term) antibody (ABIN207385)
Target
See all Interleukin enhancer-binding factor 3 (ILF3) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- Synthetic peptide corresponding to N-terminal residues of human ILF3(Interleukin enhancer-binding factor 3)
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from human ILF3.
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
- Approved: ELISA (1 μg/mL), WB (1 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.01 % sodium azide, 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- Interleukin enhancer-binding factor 3 (ILF3)
-
Alternative Name
- NF90 / ILF3
-
Background
-
Name/Gene ID: ILF3
Synonyms: ILF3, CBTF, DRBF, DRBP76, MMP4, NF-AT-90, NF90, NFAR2, Nuclear factor nf90, M-phase phosphoprotein 4, TCP110, MPHOSPH4, NF110b, NF90a, NF90b, NFAR-1, TCP80, NF110, NFAR -
Gene ID
- 3609
-
UniProt
- Q12906
-
Pathways
- M Phase
Target
-